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In Brief
As part of the International Human
Epigenome Consortium, this study
introduces EPICO, an epigenomics
comparative cyber-infrastructure to
develop comparative epigenomic web
portals to display large epigenomic
datasets. EPICO is used to implement the
BLUEPRINT Data Analysis Portal (BDAP)
for user-friendly access to BLUEPRINT
results. Explore the Cell Press IHEC web
portal at http://www.cell.com/
consortium/IHEC.
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The impact of large and complex epigenomic data-
sets on biological insights or clinical applications is
limited by the lack of accessibility by easy, intuitive,
and fast tools. Here, we describe an epigenomics
comparative cyber-infrastructure (EPICO), an open-
access reference set of libraries to develop compar-
ative epigenomic data portals. Using EPICO, large
epigenome projects can make available their rich
datasets to the community without requiring spe-
cific technical skills. As a first instance of EPICO,
we implemented the BLUEPRINT Data Analysis
Portal (BDAP). BDAP provides a desktop for the
comparative analysis of epigenomes of hematopoi-
etic cell types based on results, such as the position
of epigenetic features, from basic analysis pipelines.
The BDAP interface facilitates interactive exploration
of genomic regions, genes, and pathways in the
context of differentiation of hematopoietic lineages.
This work represents initial steps toward broadly
accessible integrative analysis of epigenomic data
across international consortia. EPICO can be ac-
cessed at https://github.com/inab, and BDAP can
be accessed at http://blueprint-data.bsc.es.
The International Human Epigenome Consortium (IHEC; IHEC,
2016) coordinates standards for the production, distribution,
and accessibility of reference epigenomes generated by several
large consortia, including BLUEPRINT (Adams et al., 2012),
CEMT (CEMT, 2016), CREST (CREST, 2016), DEEP (DEEP,
2016), ENCODE (ENCODE, 2016), CEEHRC (CEEHRC, 2016),
and NIH ROADMAP (Roadmap Epigenomics Project, 2016).
Each consortium keeps its original data on their own Data Coor-
dination Center (DCC) portal, which provides some additional
analysis results (for example, chromatin state or intron retention)
in different formats (text, BED, BigWig for the raw signal, andCellBigBed for regions highly enriched in raw signal) along with
metadata (Table S1). Moreover, some consortia provide genome
browsers to visualize and compare the primary data (Table S1).
Nevertheless, additional bioinformatics skills are needed to
identify, download, process, and analyze the large and complex
datasets (Table S1). Indeed, the majority of potential users inter-
ested in epigenomic datasets, including most biologists and
physicians, are not able to exploit the data satisfactorily. There-
fore, novel efficient exploration tools to quickly test biological
hypotheses are needed.
Here, we describe an epigenomics comparative cyber-infra-
structure (EPICO; https://github.com/inab) to facilitate the pro-
duction of user-friendly interactive web portals, and we describe
a portal for BLUEPRINT data (http://blueprint-data.bsc.es) imple-
mented using EPICO. The BLUEPRINT Consortium is a flagship
European project that aims to provide reference epigenomes
from hematopoietic cell lineages (Adams et al., 2012). Portals
created with EPICO enable the comparison of the epigenetic
structure of different cell types and related diseases.
The EPICO platform is based on five components: (1) a data
model (EPICO-data-model, 2016); (2) data validation and loading
programs (EPICO-data-loading-scripts, 2016), which must be
adapted to the data and metadata acquisition of the particular
project; (3) an empty database that will store all the data and
metadata produced by the data validation and loading pro-
grams; (4) the EPICO REST API (EPICO-REST-API, 2016), which
implements the queries to the database, providing a program-
matic access; and (5) the data analysis portal itself (BP-Data_
analysis, 2016), which queries the databases through the EPICO
REST API (Figure 1).
The minimum infrastructure needed to generate epigenomic
data portals with EPICO are the five aforementioned compo-
nents, storage space to create the database, a connection to
fetch the primary data to be integrated into the database,
and the modules to receive the queries over the stored data
and send the results to be visualized. A detailed technical
description of the EPICO components and the instructions to
create custom data portals are provided at https://github.com/
inab/epico-data-analysis-portal/wiki.Systems 3, 491–495, November 23, 2016 ª 2016 Elsevier Inc. 491
AC B
F
E
G
D1
D2
D3
(legend on next page)
492 Cell Systems 3, 491–495, November 23, 2016
The epigenomic information displayed by BDAP is based on
data obtained from chromatin immunoprecipitation sequencing
(ChIP-seq) experiments (H3K4me3, H3K4me1, H3K27ac,
H3K36me3, H3K27me3, H3K9me3, or H2A.Zac); DNaseI-
seq (DNase I sequencing); WGBS (whole-genome bisulfite
sequencing of hypo- and hyper-methylated regions); and RNA-
seq (RNA sequencing; at the gene or transcript level). As of
the 2016-08 data release, the platform contains the analysis
of 2,757 products from 2,558 experiments, involving 487 donors,
11 pool donors, and seven cell lines, and summarizing a total of
62 different cell types that cover 17 diseases. The BDAP allows
users to visualize and compare all the epigenomic and tran-
scriptomic data for blood cell types of interest. This query is
performed following the three-step process implemented in
EPICO (STAR Methods). We illustrate its utility by analyzing
two genes as examples, Formyl Peptide Receptor 1 (FPR1; Fig-
ures S1 and S2) and interferon regulatory factor 8 (IRF8; Figures
S3 and S4).
FPR1 is one of themost extensively studiedG-protein-coupled
receptors involved in neutrophil chemotaxis (reviewed by Ye
et al., 2009), We used the BDAP to explore the phase in which
neutrophil differentiation FPR1 expression is regulated (STAR
Methods). A gene expression boxplot shows a clear increase in
FPR1 expression, as neutrophil differentiation progresses from
the neutrophilic myelocyte to the mature neutrophil, and a more
modest increase for FPR2 (Figures S2A and S2B). The cell types
with the strongest expression were the segmented neutrophils of
the bone marrow and the mature neutrophils. In addition, the
ChIP-seq data revealed active histone modifications in the start
codon and transcribed regions of the principal isoforms for
FPR1 and FPR2 in the cell types with the strongest expression
(Figures S2C and S2D). These results suggest that the chemo-
tactic properties associated with FPR1 and FPR2 are acquired
during neutrophil differentiation and that they reach their peak
in the segmented neutrophils of the bone marrow.
The interferon regulatory factor 8 (IRF8) has been identified as
a key transcription factor that regulates myeloid cell production.
IRF8 maintains the balance between monocytes and neutro-
phils, and a lack of this gene increases the number of neutrophils
and diminishes the monocyte population (Kurotaki et al., 2014).
We used the BDAP to explore the differences between neutro-
phils and monocytes at the transcriptome and epigenome levels
(STAR Methods). Gene expression boxplots clearly show that
IRF8 is expressed in classical monocytes and macrophages,Figure 1. EPICO Infrastructure Flowchart
(A) Each epigenomic dataset usually has its own file formats and conventions, so
(B) EPICO data model concepts, ontologies, and restrictions are common. Only
primary database resources or project name have to be tweaked.
(C) As genomic definitions and annotations are published in common sites, and th
(D) The metadata and data insertion (which should be following the EPICO data
validation and normalization (1) using EPICO libraries (2), which later translate it int
and Elasticsearch). In the case of BLUEPRINT, we have used Elasticsearch.
(E) The data are massively inserted into the database, which already contains t
ontologies, and the genomic coordinates of the known features, like genes, tran
(F) The BLUEPRINTData Analysis Portal prior to version 1.0was issuing its queries
metadata + primary analysis data.
(G) BDAP 1.0 issues its queries to the EPICO REST API, which manages the diffe
Analysis Portal is going to be a superset of BDAP, able to work with one or more p
be mixed and compared due to different experimental, normalization, and analywhereas neutrophils do not express this transcription factor (Fig-
ure S4B). In addition, differences in the transcripts expressed
are observed (Figure S4A). Moreover, peaks of active histone
modifications H3K27ac were observed along the gene body
and at the start codon in the two cell types that express IRF8
(Figure S4D), while in neutrophilic myelocytes, repressive his-
tone modifications were situated in the region around the start
codon (H3K27me3 and H3K9me3; Figures S4C and S4E). These
results confirmed previous observations suggesting that IRF8 is
a marker of the macrophage lineage (Kurotaki et al., 2014).
Data portals facilitate access to different data analyses by
reducing the need to deal with issues related to the different
formats in which data are stored. Unfortunately, the current
lack of standards for data and metadata in epigenomics limits
the possibility of developing a single portal to compare data
of the different IHEC consortia. Given this situation, we propose
the use of EPICO to create project-specific data analysis por-
tals. EPICO includes a common template and standards for
the description of data and metadata.
The BLUEPRINT Data Analysis Portal complements the
BLUEPRINT-DCC portal (DCC_portal, 2016) by providing the
facilities to analyze multiple epigenetic data types at once—
for instance, DNA methylation and histone marks—and to
deal with multiple samples from different cell types rather
than dealing with individual samples and specific data types.
Moreover, the BDAP answers queries about specific genomic re-
gions, genes, or pathways, providing summary statistics and
comparative analysis grouping samples by cell type or tissue of
origin. The BDAP is accessible to many biologists and doctors
without programmatic or technical skills. This is different from
other solutions, such as the one recently proposed by DeepBlue
(Albrecht et al., 2016; Table S1). The BDAP is the first platform
generated with EPICO. The main condition for generating a portal
is that dataandmetadatahave tobeconverted toEPICOstandard
format (STARMethods). In the future, additional effortswill have to
be made to homogenize across IHEC experimental procedures,
quality controls, and primary data analysis workflows, a situation
reminiscent of the current developments in other large-scale con-
sortia, such as ICGC (ICGC, 2016) or ENCODE (ENCODE, 2016).
Future improvements to our platformwill include the integration
of our visualization tools (e.g., boxplots or scatterplots) and re-
sults (e.g., consensus peaks) with standard genomic browsers,
such as EnsEMBL (Flicek et al., 2014) or the UCSC (University
of California, Santa Cruz) Genome Browser (Kent et al., 2002).this step is custom.
details like the versions of reference EnsEMBL, GENCODE, GRCh, and other
eir data formats are stable from release to release, this step is done by EPICO.
model at this point) is composed of several steps, all of them generic: data
o the dependent databasemodel (3) (currently supported relational, MongoDB,
he database definitions mapped from the EPICO data model, as well as the
scripts, direct complexes, reactions, and pathways.
to the read-only instance of Elasticsearch, which contained all the BLUEPRINT
rent databases and implements the queries to Elasticsearch. The EPICO Data
roject datasets at once. Data from different epigenomic projects usually cannot
sis protocols.
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In summary, EPICO provides the infrastructure and a standard
template to create powerful tools that bring complex epigenomic
data to the hands of researchers who want to test biological
hypotheses, as shown in the two use cases of the BDAP imple-
mentation of EPICO fed with BLUEPRINT primary data.
STAR+METHODS
Detailed methods are provided in the online version of this paper
and include the following:
d KEY RESOURCES TABLE
d CONTACT FOR REAGENT AND RESOURCE SHARING
d EXPERIMENTAL MODEL AND SUBJECT DETAILS
d METHOD DETAILSB EPICO Cyber-Infrastructure Description
B BLUEPRINT Data Analysis Portal General Usage
Description
B Step-by-Step Example of BDAP Usage: FPR1
B Step-by-Step Example of BDAP Usage: IRF8
d QUANTIFICATION AND STATISTICAL ANALYSIS
d DATA AND SOFTWARE AVAILABILITY
d ADDITIONAL RESOURCES
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and one table and can be
found with this article online at http://dx.doi.org/10.1016/j.cels.2016.10.021.
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Bower package angular-route https://bower.io/ 1.5.4
Bower package angular-bootstrap https://angular-ui.github.io/
bootstrap/
1.3.3
Bower package select2-bootstrap-css https://bower.io/ 1.4.6
Bower package angular-ui-select https://bower.io/ 0.16.1
Bower package angular-tree-control https://github.com/jmfernandez/
angular-tree-control
6c71da1d8fb8b021af1e900cc53483
b08ef3bb55
Bower package highcharts-release http://www.highcharts.com/ v4.2.7
Bower package highcharts-ng https://github.com/inab/
highcharts-ng
5a3d1168caa5b47031f57d920d0752
859bb0dc95
Bower package highcharts-export-csv https://github.com/highcharts/
export-csv
7e0b0515a52519cf14908e476c59146
50b50ae38
Bower package jalette https://github.com/emersion/
jalette
b9b4108c652baef9d77ef4f32d8f0900
0c7dc2d8
Bower package simple-statistics http://simplestatistics.org/ 1.0.0
Bower package angular-plotly https://bower.io/ 0.1.3
Bower package roboto-fontface https://bower.io/ 0.4.5
Bower package ng-csv http://ngmodules.org/modules/
ng-csv
0.3.6
Other
Website for the BLUEPRINT Data Analysis Portal This paper http://blueprint-data.bsc.es/
Installation procedures of BLUEPRINT Data
Analysis Portal
This paper https://github.com/inab/epico-data-analysis-
portal/wiki
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
The experiments, datasets, and primary analysis that support the BLUEPRINT Data Analysis Portal are available at http://dcc.
blueprint-epigenome.eu/#/home and http://www.blueprint-epigenome.eu/
METHOD DETAILS
EPICO Cyber-Infrastructure Description
The storage and querying of epigenomic data poses significant challenges to analysis portals. The main problem is that data are
semi-structured and not fully organized. The analysis pipelines uses as input the results obtained by the primary analysis done by
the consortium from large epigenomic experiments, ChIP-Seq histone peaks, consolidated methylated regions and gene/transcript
expression values. All this information is difficult to index with traditional database due to both the size and nature of the datasets.
EPICO requires a file index with the metadata, including donor, specimen (blood or other tissue types), sample identifiers, status
(healthy or disease), cellular type (referred to specimen i.e., neutrophil, monocyte, etc) and the paths to access the files with the re-
sults from the analyses. The EGA/IHEC XML files by sample and experiment are required, with a description of the sample identifier,
information about origin, a description about the experiment type (i.e., ChIP-Seq, WGBS or RNA-Seq) and the type of analysis
performed.
EPICO data model includes the necessary sample tracking metadata (donors, specimens and samples), along with the details of
the experiments performed (i.e., chromatin accessibility, WGBS, MeDIP-Seq, ChIP-Seq, mRNA-Seq and others). The results of the
primary analysis pipelines have their analysis identifiers (IDs), their correspondingmetrics (z-score, -log10 q-value, FPKM andmethyl-
ation levels) and their genomic locations. These resultsmay be a genomic region, the EnsEMBL gene ID or the EnsEMBL transcript ID
with its associatedmetrics. Each result ismapped to its physical genomic region and linked to the correspondingmetadata, such that
EPICO web client can follow the path from the consolidated methylated regions, regulatory regions, expression, or histone peaks to
the samples or donors through the analysis and experiments.
EPICO platform relies on a NoSQL database infrastructure to handle large volumes of semi-structured data to be stored. The
EPICO data model validation is a key step in cases of unstructured data usually associated to the insertions in databases (i.e.,
requiring strict types, range values restriction, check valid values against a controlled vocabulary among others). We have developed
the EPICO infrastructure, which take into account both the EPICO conceptual model and the physical database technology, applying
concepts fromobject oriented programming and extended entity relationship (EER)model (Chen, 1976; Codd, 1979). The bridge data
model describes the concepts, specifications and restrictions thatmust be validated before storing the results from the analysis pipe-
lines. Both the results andmetadata are stored in a NoSQL database instance according to the definitions and restrictions of the data
model (for instance, controlled vocabularies and ontologies). EPICO software components are open access, and they are available at
https://github.com/inab
The EPICO platform is comprised of the following modules:
d The data model (EPICO-data-model, 2016), which was initially inspired on earlier data models from ICGC DCC (ICGC-DCC-
Docs, 2016), and the validation logic (BP-Schema-tools, 2015).
d The data validation and loading programs (EPICO-data-loading-scripts, 2016), which have specific parts for each project (e.g.,
BLUEPRINT). These specific parts store the public data results produced by each project for genes and transcripts. The generic
programs also store the mappings of genes to complexes, reactions andmetabolic pathways registered on REACTOME (Croft
et al., 2014), as well as additional public data (for instance, principal isoform, start and stop codons or TSSs) from EnsEMBL
(Flicek et al., 2014), GENCODE (Harrow et al., 2012) and APPRIS (Rodriguez et al., 2013).
d The underlying database, where all the entries are kept, as well as a copy of the data model and the controlled vocabularies
(used by EPICO web client). The NoSQL database system used for BLUEPRINT deployments is Elasticsearch.
d The EPICOREST API, which implements the database queries, providing a programmatic access to the data independent from
the database technology (EPICO-REST-API, 2016)
d The data analysis portal itself (BP-Data_analysis, 2016), which fetches the data relevant to the queries, consolidating them on
the fly in mean data series for the different charts and views. EPICO web client has been built using web technologies and li-
braries, including HTML5, SVG, ES5; AngularJS, UI Bootstrap, Jallete, Ng-CSV, D3, Highcharts, Simple Statistics, Plotly and
Angular Plotly.BLUEPRINT Data Analysis Portal General Usage Description
In the first step (Figures S1A and S3A) the user introduces the query of interest, which can be a combination of genomic coordinate
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GENCODE (Harrow et al., 2012) or REACTOME (Croft et al., 2014). In addition, the user can define a flanking window around the
feature to explore the genomic context. In the case of complex features, like pathways or complexes, the genomic regions of all
the involved genes are shown. Moreover, the search box understands a basic search language that includes coupling (e.g.,
‘‘gene:BRCA1 + gene:BRCA2’’) and difference operators (e.g., ‘‘pathway:Cell Cycle, Mitotic – gene:PLK1’’).
In the second step BDAP shows a set of tabs with all the genomic regions obtained from the initial user query. In each one of these
tabs the web platform shows the query, a textual description of the genome layout, (i.e., the genes and transcripts in that region), and
it allows themetadata of the samples and the products of the analysis related to the query to be inspected and saved. The 62 primary
cell types from the hematopoietic lineage tree involved into 2016-08 release are mapped to Cell Ontology terms (Smith et al., 2007),
as implemented in EPICO. The cell lines are described in EFO (Experimental Factor Ontology; Malone et al., 2010) and Cell Line
Ontology (Sarntivijai et al., 2014), and the terms have links to the corresponding ontology descriptions. These ontologies do not
necessarily reflect all the aspects of differentiation, but as they are built connecting each term (cell type) by relationships of ‘‘is_a’’
and ‘‘develops_from’’ (Bard et al., 2005), the ontology structures in part recapitulate the hematological differentiation. For instance,
Cell Ontology has been used to study cell identity along the hematological differentiation pathways (Meehan et al., 2013).
The user selects the cell types and cell lines of his/her interest from the simplified ontology trees (Figures S1B and S3B). The num-
ber of samples is shown in function of the cell type and name for each of the selected terms, along with the results of the query region.
Procedures that facilitate easy ontological sub-tree selection and ancestor de-selection are implemented in the system.
Finally, in the third step the user can select the initial analytical charts corresponding to the cell types for which epigenomics
information is available, including ChIP-Seq (H3K4me3, H3K4me1, H3K27ac, H3K36me3, H3K27me3, H3K9me3 or H2A.Zac),
DNaseI-Seq, WGBS (hypo and hyper-methylated regions) and RNA-Seq (gene or transcript level; Figures S1C and S3C). Also,
the user can choose to focus on a specific disease in the shown cell types, as long as there are samples from those cell types diag-
nosed by that disease.
Once the three-step process is completed BDAP displays the results in a graphic form and in tables (BP-analysis, 2016). Results
are distributed in three different views, the ‘‘General View’’ uses the different cell types as the data series for the plots, and allows to
filter by disease status. The ‘‘By tissue’’ view allows finer grain analysis of specific tissues of origin. The ‘‘Diseases by cellular type’’
view uses as data series the different diseases and normal states, and allows the comparison with a set of cellular types.
RNA-Seq data is represented in box-plots as an expression value for the whole gene or for each transcript (Fragments Per Kilobase
Million; BP-FPKM, 2016) and by heatmaps used to show pairwise t test comparisons (at p value level) between pairs of cellular types
on the same gene or transcript. The graphs of the ChIP-Seq, DNaseI-Seq and Methylation data are spline+ribbon-based scatter-
plots that represent the genomic coordinates on the x axis and the averaged (solid line), minimum and maximum (shadow area)
-log10(p value), z-values or methylation levels for the ChIP-Seq, DNA-Seq and WGBS experiments on the y axis, respectively.
These graphs also include a graphical representation of the genomic layout on the inspected genomic coordinates as special se-
ries. Genes in the genomic region are included in this graphical representation, showing in its condensedmode the transcript, exons,
UTR, CDS and TSS (start and stop codons) corresponding to the principal isoform of each gene, as identified by APPRIS (Rodriguez
et al., 2013).
The graphs are distributed in a fluid grid, which adapts to different screen sizes and resolutions for a better user experience when
using BDAP in mobile devices. Moreover, these graphs have interactive features, like the capacity to zoom in and out on the data (all
the graphs are updated at once), show and hide the legend, and switch the shown genomic layout between the condensed repre-
sentation and a complete one, which includes all the transcripts. High quality renderings of each plot can be saved using their context
menu for publication in png, jpeg, pdf and svg formats. The entire data series can also be downloaded in csv and xls formats for
further analysis. The disease filtering menu, the list of available charts and the list of cell types with data in the query region are
on the left of the grid. The user can show or hide the data series related to each cell type by clicking on it, as well as inspect the sample
names and the number of samples with data in the query region.
The user can also inspect the first data entries used to compute the visible series on a specific chart. This supporting data contains
the coordinates of the ChIP-Seq and the DNaseI-Seq peaks, the hypo- and hypermethylated regions and/or the RNA-Seq expression
levels. From this view, all the supporting data can be downloaded in a tabular format.
BDAP’s Browser URL is rewritten on each query, cell type and chart selection allowing to bookmark them for later inspection.
Additional links to the BLUEPRINT DCCportal (DCC_portal, 2016) and themainweb page of the project are also provided. Through
these links the user can browse the raw and processed data produced by the consortium, as well as a description of themethods and
results, the groups participating, and the publications associated to the BLUEPRINT data.
Step-by-Step Example of BDAP Usage: FPR1
In the first step the user introduces the query of interest, FPR1, in the search box and in this case, we selected 500 bp in the flanking
window size box to also explore the gene’s local upstream and downstream regions (Figure S1A). In the second step the 62 primary
cell types from the hematopoietic lineage tree involved into 2016-08 release are mapped to Cell Ontology terms (Smith et al., 2007).
We selected the neutrophil terms based on the cell ontology hierarchy: neutrophilic myelocyte; neutrophilic metamyelocyte; band
form neutrophil; segmented neutrophil of bone marrow; and mature neutrophil (Figure S1B). Finally, in the third step, from the epi-
genomic information available, we selected the gene expression and pairwise t test comparisons charts (from RNA-Seq) and all
the histone peaks (from ChIP-Seq experiments) for H3K27Ac, H3K36me3 and H3K4me3 filtering by normal cell types to explore
the FPR1 data from the neutrophil differentiation lineage (Figure S1C).Cell Systems 3, 491–495.e1–e5, November 23, 2016 e4
BDAP displayed the data for FPR1, and for its paralogs FPR2 and FPR3, as these genes overlap completely or partially with the
longest FPR1 transcript annotated in EnsEMBL (Figure S2).
Step-by-Step Example of BDAP Usage: IRF8
We started the search introducing the gene symbol ‘‘IRF8’’ in the first step and with a flanking window size of 500 bps (Figure S3A).
We then selected the neutrophilicmyelocyte term, the classicalmonocyte and themacrophage terms in the second step (Figure S3B),
and for the experimental results in the third step, we selected gene and transcript expression and the histone modification charts for
H3K27ac, H3K27me3 and H3K9me3 filtering by normal cell types (Figure S3C).
QUANTIFICATION AND STATISTICAL ANALYSIS
BLUEPRINT Data Analysis Portal display information from the official pipelines to analyze the data produced by the project. This in-
formation is public available across BLUEPRINT-DCC or ftp site.
Detailed information about the parameters and statistics produced by BLUEPRINT and displayed by BDAP is available at:
For hypo and hyper-methylated regions: http://dcc.blueprint-epigenome.eu/#/md/bs_seq_grch38
For ChIP-seq experiments: http://dcc.blueprint-epigenome.eu/#/md/chip_seq_grch38
For DNase-seq experiments: http://dcc.blueprint-epigenome.eu/#/md/dnase_seq_grch38
For RNA-seq experiments: http://dcc.blueprint-epigenome.eu/#/md/rna_seq_grch38
The statistics displayed in the boxplot charts (median, mean, quartiles, maximum, minimum and outliers) are computed and rep-
resented with Plotly library (https://plot.ly/)
The Welch’s t test calculated for the pairwise t test comparison charts is done by Simple Statistics library (http://simplestatistics.
org/). These charts present the p value resulted from the test without cut-off selection. The t test comparisons are made on the fly.
DATA AND SOFTWARE AVAILABILITY
The BLUEPRINT Data Analysis Portal is available at http://blueprint-data.bsc.es/#!/
The EPICO components can be downloaded at:
1. EPICO-data-model: https://github.com/inab/EPICO-data-model
2. EPICO-data-loading-scripts: https://github.com/inab/EPICO-data-loading-scripts
3. EPICO-REST-API: https://github.com/inab/EPICO-REST-API
The BLUEPRINT Data Analysis Portal components can be downloaded at:
1. BP-Schema-Tools: https://github.com/inab/BP-Schema-tools
2. Epico-data-analysis-portal: https://github.com/inab/epico-data-analysis-portalADDITIONAL RESOURCES
The EPICO guide installation and usage is available at https://github.com/inab/epico-data-analysis-portal/wiki
A first steps tutorial about BLUEPRINT Data Analysis Portal usage is available at http://blueprint-data.bsc.es/#!/first-steps
An example usage of BLUEPRINT Data Analysis Portal is available at: http://blueprint-data.bsc.es/#!/doing-a-search
The experiments, datasets and primary analysis that support the BLUEPRINT Data Analysis Portal are available at http://dcc.
blueprint-epigenome.eu/#/home
The BLUEPRINT consortium data portal is available at http://www.blueprint-epigenome.eu/e5 Cell Systems 3, 491–495.e1–e5, November 23, 2016
